Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ono Pharmaceutical Co., Ltd. (OTC: OPHLF).

Full DD Report for OPHLF

You must become a subscriber to view this report.

Recent News from (OTC: OPHLF)

3 Things In Biotech, April 29: Bristol-Myers Widens, Ono Takes On Pheo, BrainStorm's ALS Adventure Moves Forward
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Here is some more information if you're curious . Welcome to another edition of "3 Things In Biotech," a daily digest dedicated...
Source: SeekingAlpha
Date: April, 30 2018 08:00
Ono Pharma exercises option for Merus Biclonics technology for autoimmune bispecific antibody
Merus N.V. (NASDAQ: MRUS ) announces that collaboration partner Ono Pharmaceutical ( OTC:OPHLF )( OTCPK:OPHLY ) has exercised its option to enter into a new research and license agreement to use its Biclonics technology platform to develop a bispecific antibody targeting autoimmune disorde...
Source: SeekingAlpha
Date: March, 14 2018 07:28


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OPHLF.

About Ono Pharmaceutical Co., Ltd. (OTC: OPHLF)

Logo for Ono Pharmaceutical Co., Ltd. (OTC: OPHLF)

Production, purchase and sale of pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals


Contact Information



Current Management

  • Gyo Sagara / CEO

Current Share Structure

  • Market Cap: $14,448,103,500 - 03/15/2018
  • Issue and Outstanding: 589,237,500 - 04/01/2016


Recent Filings from (OTC: OPHLF)

Post-effective amendment to a previously filed F-6
Filing Type: F-6 POSFiling Source: edgar
Filing Date: September, 29 2017



Daily Technical Chart for (OTC: OPHLF)

Daily Technical Chart for (OTC: OPHLF)

Stay tuned for daily updates and more on (OTC: OPHLF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: OPHLF)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OPHLF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OPHLF and does not buy, sell, or trade any shares of OPHLF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: